Mk 677 is a recurring topic in our peptide coverage. This hub collects every article tagged Mk 677, newest first, each evidence-graded and tied to real, verifiable sources.
A clinical explainer separating true peptides from the SARMs, small-molecule drugs, hormones, and supplements sold beside them on the same gray-market storefronts. Chemistry, evidence, FDA status, and anti-doping rules are all class-specific.
An evidence-ranked look at the peptides marketed for sleep — DSIP, MK-677, epitalon, CJC-1295 and ipamorelin. The honest headline: no peptide is a proven insomnia treatment, and the best human data are tiny and decades old.
An evidence-first ranking of the GH secretagogues sold for 'growth hormone optimization' — tesamorelin, MK-677, CJC-1295, sermorelin and ipamorelin — separating what raises GH/IGF-1 in humans from what only sounds like it should.
A clinical monograph on MK-677 (ibutamoren) — the oral, non-peptide ghrelin-receptor agonist that reliably raises GH and IGF-1, yet failed its clinical disease endpoints and carries a congestive-heart-failure safety signal.
Mk 677 is a topic our editors cover across the site. This hub aggregates the related, evidence-graded guidance.
This hub updates automatically whenever a new article is tagged Mk 677, so the latest coverage appears first.
Yes. Every article here grades its efficacy claims A-D and cites real, verifiable studies, regulatory documents or trial registries.
The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.
Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.
Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.
Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.
This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.